Bioniche Life Scienc (BNHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2016 | 06-2015 | 06-2014 | 06-2013 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 2,873 | -12,342 | -39,484 | -33,653 |
| Depreciation Amortization | 860 | 1,012 | 2,039 | 2,514 |
| Income taxes - deferred | N/A | N/A | 320 | 169 |
| Other Working Capital | -548 | 1,991 | -1,339 | 2,318 |
| Other Operating Activity | -4,008 | 2,109 | 21,900 | 15,367 |
| Operating Cash Flow | $-822 | $-7,230 | $-16,564 | $-13,285 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -26,723 | N/A | N/A | N/A |
| PPE Investments | -632 | -135 | 1,383 | -446 |
| Net Acquisitions | N/A | N/A | 53,865 | N/A |
| Purchase Sale Intangibles | -27 | -11 | -2 | -509 |
| Other Investing Activity | -27 | -591 | -1,896 | -367 |
| Investing Cash Flow | $-27,383 | $-726 | $53,352 | $-813 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 0 | 7,807 | 0 |
| Debt Repayment | -395 | -548 | -41,121 | -1,018 |
| Common Stock Issued | 33,799 | 5,532 | 9,171 | 1 |
| Other Financing Activity | -4,487 | -2,440 | -7,125 | -377 |
| Financing Cash Flow | $28,917 | $2,545 | $-31,269 | $-1,393 |
| Exchange Rate Effect | -27 | N/A | N/A | 121 |
| Beginning Cash Position | 3,140 | 8,971 | 4,289 | 19,938 |
| End Cash Position | 3,826 | 3,559 | 9,809 | 4,567 |
| Net Cash Flow | $685 | $-5,411 | $5,519 | $-15,371 |
| Free Cash Flow | ||||
| Operating Cash Flow | -822 | -7,230 | -16,564 | -13,285 |
| Capital Expenditure | -632 | -145 | -124 | -451 |
| Free Cash Flow | -1,454 | -7,374 | -16,688 | -13,736 |